Cummulative gross sales.

No definition available.

Name:	GTBP_CummulativeGrossSales
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Gross sales.

+ References

No definition available.

+ Details

Name:	GTBP_GrossSales
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum bid price requirement description.

+ References

No definition available.

+ Details

Name:	GTBP_MinimumBidPriceRequirementDescription
Namespace Prefix:	GTBP_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Outstanding commitments.

+ References

No definition available.

+ Details

Name:	GTBP_OutstandingCommitments
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Performance milestone payments.

+ References

No definition available.

+ Details

Name:	GTBP_PerformanceMilestonePayments
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Received upfront payment.

+ References

No definition available.

+ Details

Name:	GTBP_ProceedsFromUpfrontAmount
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Royalty expense year five and thereafter.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyExpenseYearAfterFive
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty expense year after six.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyExpenseYearAfterSix
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty expense year one.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyExpenseYearOne
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty expense year one though four.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyExpenseYearOneThoughFour
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty expense year two through five.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyExpenseYearTwoThroughFive
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty fee percentage.

+ References

No definition available.

+ Details

Name:	GTBP_RoyaltyFeePercentage
Namespace Prefix:	GTBP_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Sales milestone payments.

+ References

No definition available.

+ Details

Name:	GTBP_SalesMilestonePayments
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Sales revenue.

+ References

No definition available.

+ Details

Name:	GTBP_SalesRevenue
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Upfront license fee.

+ References

No definition available.

+ Details

Name:	GTBP_UpfrontLicenseFee
Namespace Prefix:	GTBP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Cost of maintenance incurred and directly related to good produced and service rendered.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_CostMaintenance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482645/405-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.W.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479583/944-40-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of damages paid to the plaintiff in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

+ Details

Name:	us-gaap_LossContingencyDamagesPaidValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.

+ References

+ Details

Name:	us-gaap_LossContingencyDamagesSought
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The value (monetary amount) of the award the plaintiff seeks in the legal matter.

+ References

+ Details

Name:	us-gaap_LossContingencyDamagesSoughtValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash outflow for cost incurred directly with the issuance of an equity security.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-15

+ Details

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash outflow for the payment of debt classified as other.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 15
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-15

+ Details

Name:	us-gaap_RepaymentsOfOtherDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479532/912-730-25-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	us-gaap_UnbilledReceivablesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandTwentyThreeSponsoredResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandSixteenPatentLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=GTBP_TwoThousandSeventeenThroughTwoThousandTwentyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=GTBP_TwoThousandTwentyTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=GTBP_TwoThousandTwentyFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=GTBP_TwoThousandTwentySevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=GTBP_TwoThousandTwentySixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandAndTwentyOnePatentLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandTwentyOneExclusiveLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandTwentyFourGtbThreeSixFiveZeroClinicalTrialAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_TwoThousandTwentySixGtbFiveThousandFiveFiftyClinicalTrialAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_AdvisoryAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=GTBP_AmendedAdvisoryAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=GTBP_ZOneLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=GTBP_CobySilberfeinMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=GTBP_JustinDiPietroMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=GTBP_PhillipWerthmanTrustMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details Narrative) - USD ($)																1 Months Ended	3 Months Ended		6 Months Ended		9 Months Ended
	Aug. 10, 2026	Jul. 10, 2026	Apr. 03, 2026	Apr. 01, 2026	Mar. 26, 2026	Sep. 02, 2025	Jul. 09, 2025	Jul. 08, 2025	Jun. 18, 2025	Feb. 17, 2025	Nov. 18, 2024	May 20, 2024	May 13, 2024	Mar. 26, 2021	Jul. 18, 2016	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2026	May 20, 2026
Loss Contingencies [Line Items]
Principal amount						$ 150,000
Damages sought value						$ 100,000
Loss contingency, owes damages						500,000
Research and development expense																	$ 1,055,000	$ 363,000	$ 1,468,000	$ 1,462,000
Outstanding commitments																	108,000		108,000
Stock issuance																			$ 1,100,000
Minimum bid price requirement description																			had closed below $1.00 per share for 30 consecutive business days and, as a result, the Company was not in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
Share Price																						$ 1.00
2023 Sponsored Research Agreement [Member]
Loss Contingencies [Line Items]
Aggregate research and development expense					$ 2,000,000				$ 1,900,000			$ 1,700,000
Payments of research and development					$ 108,000				$ 216,000
Research and development expense																			$ 216,000	432,000
2023 Sponsored Research Agreement [Member] \| Subsequent Event [Member]
Loss Contingencies [Line Items]
Aggregate research and development expense	$ 2,300,000
Payments of research and development		$ 216,000
2016 Exclusive Patent License Agreement [Member]
Loss Contingencies [Line Items]
Proceeds from upfront amount													$ 145,000		$ 200,000
License maintenance fees															100,000
Royalty fee percentage													6.00%
Performance milestone payments													$ 3,100,000		3,100,000
One-time sales milestone payments													1,000,000		1,000,000
Gross sales													250,000,000		250,000,000
Sales revenue													5,000,000		5,000,000
Cumulative gross sales													500,000,000		$ 500,000,000
Royalty expense year one													250,000
Royalty expense years two through five													2,000,000
Royalty expense year six and thereafter													$ 5,000,000
2016 Exclusive Patent License Agreement [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Royalty fee percentage													1.00%		4.00%
2016 Exclusive Patent License Agreement [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Royalty fee percentage													5.00%		6.00%
2016 Exclusive Patent License Agreement [Member] \| 2017 through 2020 [Member]
Loss Contingencies [Line Items]
License maintenance fees															$ 200,000
2016 Exclusive Patent License Agreement [Member] \| Beginning in 2022 [Member]
Loss Contingencies [Line Items]
Annual royalty payments															250,000
2016 Exclusive Patent License Agreement [Member] \| Beginning in 2025 [Member]
Loss Contingencies [Line Items]
License maintenance fees													$ 50,000
Annual royalty payments															2,000,000
2016 Exclusive Patent License Agreement [Member] \| Beginning in 2027 [Member]
Loss Contingencies [Line Items]
Annual royalty payments															$ 5,000,000
2016 Exclusive Patent License Agreement [Member] \| Beginning in 2026 [Member]
Loss Contingencies [Line Items]
License maintenance fees													$ 100,000
2021 Exclusive License Agreement [Member]
Loss Contingencies [Line Items]
Performance milestone payments														$ 3,100,000
One-time sales milestone payments														1,000,000
Gross sales														250,000,000
Sales revenue														5,000,000
Cumulative gross sales														500,000,000
Upfront license fee														20,000
Royalty expense year one though four														250,000
Royalty expense year five and thereafter														$ 2,000,000
2021 Exclusive License Agreement [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Royalty fee percentage														2.50%
2021 Exclusive License Agreement [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Royalty fee percentage														5.00%
2021 Exclusive License Agreement [Member] \| Beginning in 2022 [Member]
Loss Contingencies [Line Items]
License maintenance fees														$ 5,000
2021 Exclusive License Agreement [Member]
Loss Contingencies [Line Items]
Research and development expense																			100,000	0
2024 GTB-3650 Clinical Trial Agreement [Member]
Loss Contingencies [Line Items]
Research and development expense																			168,000	$ 4,000
Annual royalty payments											$ 2,000,000
Unbilled and unaccrued amounts																	800,000		800,000
2026 GTB-5550 Clinical Trial Agreement [Member]
Loss Contingencies [Line Items]
Annual royalty payments			$ 3,800,000
Unbilled and unaccrued amounts																	$ 3,800,000		$ 3,800,000
Advisory Agreement [Member]
Loss Contingencies [Line Items]
Cash payment																$ 100,000
Pre-funded warrant to purchase shares of common stock																150,000		150,000		150,000
Stock issuance																$ 537,000
Amended Advisory Agreement [Member]
Loss Contingencies [Line Items]
Cash payment																					$ 150,000
Pre-funded warrant to purchase shares of common stock				400,000
Stock issuance				$ 164,000
Z-One, LLC [Member]
Loss Contingencies [Line Items]
Principal amount										$ 150,000
Damages sought value										$ 500,000
Coby Silberfein [Member]
Loss Contingencies [Line Items]
Damages sought value								$ 100,000
Justin DiPietro [Member]
Loss Contingencies [Line Items]
Principal amount								$ 100,000
Phillip Werthman Trust [Member]
Loss Contingencies [Line Items]
Principal amount							$ 100,000